These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27593571)

  • 1. Development of risperidone liposomes for brain targeting through intranasal route.
    Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY
    Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of valproic acid liposomes for delivery into the brain through an intranasal route.
    Jufri M; Yuwanda A; Surini S; Harahap Y
    Heliyon; 2022 Mar; 8(3):e09030. PubMed ID: 35284670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
    Shi YJ; Zhang XF; Guo QT
    Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
    Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
    Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
    Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
    Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
    Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
    Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting.
    Ahammed V; Narayan R; Paul J; Nayak Y; Roy B; Shavi GV; Nayak UY
    Life Sci; 2017 Aug; 183():11-20. PubMed ID: 28647214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Brain Delivery
    Arya RKK; Vijay J; Bisht D; Rashid M; Alfawaz Altamimi AS; Afzal O; Sethiya NK
    Curr Drug Deliv; 2023; 20(5):587-600. PubMed ID: 35598246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic synthesis of multifunctional liposomes for tumour targeting.
    Ran R; Middelberg APJ; Zhao CX
    Colloids Surf B Biointerfaces; 2016 Dec; 148():402-410. PubMed ID: 27639490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7.
    Gandhi R; Khatri N; Baradia D; Vhora I; Misra A
    Drug Deliv; 2016 May; 23(4):1152-62. PubMed ID: 25586675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and properties of folate receptor-targeted cationic liposomes].
    Yan Y; Qi XR
    Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone.
    Abdelrahman FE; Elsayed I; Gad MK; Elshafeey AH; Mohamed MI
    Int J Pharm; 2017 Sep; 530(1-2):1-11. PubMed ID: 28733244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution.
    Abdelrahman FE; Elsayed I; Gad MK; Badr A; Mohamed MI
    Int J Pharm; 2015 Jul; 490(1-2):281-91. PubMed ID: 26026251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
    Kumar M; Misra A; Babbar AK; Mishra AK; Mishra P; Pathak K
    Int J Pharm; 2008 Jun; 358(1-2):285-91. PubMed ID: 18455333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity.
    Prabhu P; Shetty R; Koland M; Vijayanarayana K; Vijayalakshmi KK; Nairy MH; Nisha GS
    Int J Nanomedicine; 2012; 7():177-86. PubMed ID: 22275833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.